대한예방한의학회지 (Journal of Society of Preventive Korean Medicine)

대한예방한의학회 (Society of Preventive Korean Medicine)
권호 표지
DOI QR코드

DOI QR Code

우리나라의 한약 부작용 규모 추정

Estimation of Adverse Events Scale relating Herbal Medicine in Korea

  • 우연주 (상지대학교 한의과대학 생리학교실)
  • Woo, Yeonju (Department of Physiology, College of Korean Medicine, Sangji University)
  • 투고 : 2020.04.13
  • 심사 : 2020.04.26
  • 발행 : 2020.04.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives : The purpose of study was estimation of adverse events [AEs] scale relating herbal medicine in Korea using Korean Medicine Utilization and Herbal Medicine Consumption Survey (National statistics No. 117087). Methods : Using microdata of Korean Medicine Utilization and Herbal Medicine Consumption Survey 2017, the number of inpatients and outpatients who experienced AEs was calculated. The microdata included AEs of all treatment methods that have been performed by visiting Korean medical institutions for one year, so set up the data into three models; model A (in case all treatments were only herbal medicine for one year), model B (in case herbal medicines were a part of all treatment methods in 1 year), model C (in case herbal medicines were a part of treatment methods at least one time in 1 year). The proportion of patients who experienced AEs during the last 1 year was calculated and then, the number of AEs relating herbal medicine was estimated. Results : A total of 1,010 outpatients and 904 inpatients were included in Korean Medicine Utilization and Herbal Medicine Consumption Survey 2017. The number of patients who had experienced AEs in the past 1 year was 0 in the model A, 9 in the model B (5 for outpatients, 4 for inpatients), and 19 in the model C (10 for outpatients, 9 for inpatients). By consideration for the complex sample survey, estimating the number of AEs relating herbal medicine, the model A was 0, the model B was 36,457 patients (0 to 75,526 patients), and the model C was 84,830 patients (26,314 to 143,347 patients). Conclusion : From the results of this study, it was possible to estimate the scale of AEs relating herbal medicines in Korea, suggesting that it is necessary to understand the actual condition of AEs and establish its management system.

키워드

참고문헌

  1. Korean Society for Pharmacoepidemiology and Risk Management. Pharmacoepidemiology 2nd Ed. Seoul: SNU Press; 2012
  2. Choi D, Choi M, Ko A. Current status of pharmaceutical safety management in Korea. J Korean Med Assoc 2012;55:827-34 https://doi.org/10.5124/jkma.2012.55.9.827
  3. 식품의약품안전처. 2019 식품의약품통계연보 제21호. 2019
  4. 국민건강보험공단 보도자료. 건강보험 빅데이터로 "약물 부작용 줄이고, 국민안전 올리고!". available from https://www.nhis.or.kr/menu/retriveMenuSet.xx?menuId=D4000 [cited on 2020. 1. 31.]
  5. 최혁재. 의료기관내 한약부작용 보고현황과 활용방안. 2017년 대한약물역학위해관리학회 추계학술대회 발표자료.
  6. 보건복지부, 한약진흥재단. 2017년 한방의료이용 및 한약소비실태조사 마이크로데이터 이용지침서. 2018
  7. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients; a meta-analysis of prospective studies. JAMA 1998;279(15):1200-5 https://doi.org/10.1001/jama.279.15.1200
  8. Bourgeois FT, Shannon MW, Valim C et al. Adverse drug events in the outpatient setting: an 11-year national analysis. Pharmacoepidemiol Drug Saf 2010;19(9):901-10 https://doi.org/10.1002/pds.1984
  9. Pirmohamed M, James S, Meakin S et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18,820 patients. BMJ 2004;329(7456):15-9 https://doi.org/10.1136/bmj.329.7456.15
  10. Jha AK, Kuperman GJ, Rittenberg E et al. Identifying hospital admissions due to adverse drug events using a computer-based monitor. Pharmacoepidemiol Drug Saf 2001;10(2):113-9 https://doi.org/10.1002/pds.568
  11. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001;41(2):192-9
  12. Cho JH, Oh DS, Hong SH, et al. A nationwide study of the incidence rate of herb-induced liver injury in Korea. Archives of Toxicology 2017;91(12):4009-15 https://doi.org/10.1007/s00204-017-2007-9
  13. Jeong TY, Park BK, Cho JH, et al. A prospective study of the safety of herbal medicines, used alone or with conventional medicines, Journal of Ethnopharmacology 2012;143:884-8 https://doi.org/10.1016/j.jep.2012.08.016
  14. Lee KB, Park Y, Lee S. Characteristics of Toxicity Occurring in Outpatients at Korean Medical Clinics in Korean. The Journal of Korean Oriental Medicine 2016;37(1):135-150 https://doi.org/10.13048/jkm.16013
  15. 의약품의 품목허가.신고.심사 규정. 식품의약품안전처 고시 제2019-26호. available from http://www.law.go.kr/행정규칙/의약품의품목허가.신고.심사규정/(2019-26,20190329) [cited on 2020. 3. 31]